Covid-19 vaccine unlikely before early or mid-2021: WHO Southeast Asia head

Even the front-runners among vaccine companies would take at least a few months to complete Phase-III trials and evaluate the efficacy and safety of individual vaccines

Poonam Khetrapal Singh
Premium

“While the vaccine pipeline looks promising, we cannot say with certainty when a vaccine will be available for administration to populations,” Dr Poonam Khetrapal Singh, Southeast Asia Regional Director, WHO

Ruchika Chitravanshi New Delhi
Even as several countries were planning to roll out coronavirus vaccines as early as in December or January, doses of these vaccine were unlikely to available before early- or mid-2021, World Health Organization (WHO) Southeast Asia Regional Director Dr Poonam Khetrapal Singh told Business Standard.
 
“It is hoped that if a successful vaccine is found within the next few months, enough doses will be available for countries by the end of 2021 so that those in priority populations who choose to be vaccinated have access to them,” Singh said. 
 
Even the front-runners among vaccine companies would take at least a few months to complete Phase-III trials and evaluate the efficacy and safety of individual vaccines, she said. Add

Also Read

Coronavirus vaccine update: Mexico gets 1st doses of Chinese vaccine COVAX

Russian vaccine on its way to India, pact signed with Dr Reddy's for trials

Covid vaccine updates: Key facts and major announcements you should know

Coronavirus vaccine update: Covid drug, AstraZeneca vaccine current status

Coronavirus vaccine update: Moderna vaccine trial delayed, India's by Aug15

India Coronavirus Dispatch: Has the Aarogya Setu app been effective?

CAIT opposes proposal to impose lockdown in market areas in Delhi

World Coronavirus Dispatch: US stocks at new high over Moderna vaccine data

Telangana coronavirus update: State reports 952 new Covid-19 cases

DATA STORY: India reports lowest single-day jump in total cases since July 14

First Published: Nov 17 2020 | 3:09 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com